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Received 29 August 2016; accepted 17 September 2016Abstract Introduction: When cytology for pleural ﬂuid is nondiagnostic, thoracoscopy or cutting-
needle pleural biopsy or closed percutaneous needle biopsy using Abrams needle (ANPB) can be
used to obtain tissue samples. Ultrasound guidance for biopsies performed with an Abrams needle
can be used to increase the diagnostic yield of this traditional method.
Aim of the study: This study aimed to compare the diagnostic validity of ANPB under ultra-
sound guidance (US-ANPB) with that of medical thoracoscopy in patients with pleural effusion.
Methods: 30 patients with recurrent exudative pleural effusion of undetermined etiology that
have undergone cytologic analysis and could not be diagnosed were included in the study and
divided into 2 groups, Group I who underwent medical thoracoscopy for diagnosis (n = 15) and
Group II who underwent ultrasound-guided Abrams needle biopsy for diagnosis (n = 15). Com-
parison between the two groups was drawn in terms of diagnostic sensitivity and complications
associated with the methods used.
Results: The sensitivity and speciﬁcity of diagnostic thoracoscopy in group I was 100% & 100%
respectively. The sensitivity and speciﬁcity of ultrasound-guided Abrams needle in group II was
100% & 100% respectively. No difference was identiﬁed between the sensitivities of the two meth-
ods. Complications of both groups were of low rate and tolerable.
Conclusion: If US guidance can be used for biopsies performed with an Abrams needle, the yield
of this traditional method can be increased. The use of US-guided Abram’s needle pleural biopsy is
simple, safe and well tolerated.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).cal tho-
Table 1 Characteristics of patients of both groups.
Gp I (Medical
thoracoscopy) n = 15
Gp II (US-
ANPB) n = 15
P
value
Age (years,
mean ± SD)
56.5 ± 14.2 58.0 ± 12.2 0.223
Sex (M/F) 13/2 12/3 0.641
Side of eﬀusion
(right/left)
7/8 7/8 0.578
Pleural
thickening
8 7 0.569
2 E.G. Hassanein et al.Introduction
Pleural disease often presents by pleural effusion. In case of
high clinical suspicion of malignancy in patients with such a
ﬁnding, cytology of pleural ﬂuid is recommended [1].
Cytological examination of pleural ﬂuid for malignant cells
establishes a positive diagnosis of malignancy in only 60% of
effusions due to lung cancer [2–9] and 30% of effusions sec-
ondary to mesothelioma [10].
In some cases, cytology is nondiagnostic. Traditionally in
such circumstances, closed percutaneous needle biopsy has
been performed blindly using a needle, such as an Abrams
or Ramel needle [11–13].
Despite the substantial burden of pleural disease, few trials
have been done to assess the optimum diagnostic method, and
no improvement has been made in the technique of needle
pleural biopsy, which has been used for over 40 years [14].
The standard technique uses a reverse bevel needle, such as
the Abrams’ needle [6,15,16] with local anaesthetic and with-
out image guidance. This technique is associated with a sub-
stantial incidence of complications, including pneumothorax,
haemothorax, and empyema, and in rare cases can be fatal
[2,4–6,17]. Furthermore, yield over pleural ﬂuid cytology alone
is increased by only 7–26% [3,5,17] and the procedure is pain-
ful, especially when done by inexperienced operators.
Moreover, needle biopsy for pleural tissue was diagnostic in
only 50% of patients presenting with malignant effusions [3].
For this reason; the role of closed pleural needle biopsy in
diagnosing malignant effusions has been questioned [3–5].
Adding image guidance to needle biopsy may improve its
yield. Ultrasound is most frequently used to evaluate or guide
aspiration in patients with suspected pleural effusions seen on
CXR. The intercostal spaces are used as sonographic windows
[18].
US-guided cutting-needle biopsy of pleural tissue associ-
ated with a pleural effusion is a relatively new technique com-
pared with Abrams’ biopsy. Results suggest this technique
might improve diagnostic sensitivity to about 80% for pleural
malignancy [17–20].
If US-guided biopsy is strikingly superior to traditional
Abrams’ biopsy, this technique would produce better diagnos-
tic yield—and fewer complications and greater acceptability to
patients.
Patients and methods
Thirty patients with undiagnosed exudative pleural effusion
were included in this study which was conducted in the Chest
Diseases Department, Alexandria University. Informed con-
sent was obtained from all the participants before the study.
All patients were subjected basically to thorough history-
taking and clinical examination, routine laboratory investiga-
tions, plain chest radiography (posteroanterior and lateral
views), CT chest and thoracocentesis. The pleural ﬂuid
obtained was examined for the following: gross appearance
and nature of the ﬂuid, total and differential cell count, total
protein and albumin content (g/dl), lactate dehydrogenase
enzyme, Ziehl-Neelsen stain for acid fast bacilli, cytological
examination for malignant cells and bacteriological examina-
tion by culture and sensitivity.Please cite this article in press as: E.G. Hassanein et al., Comparative study between
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Group I: included 15 patients to whom medical thoracoscope
was applied for diagnosis of etiology of exudative pleural
effusion.
Group II: included 15 patients to whom US-guided
Abram’s needle was applied for diagnosis of etiology of exuda-
tive pleural effusion.
Medical thoracoscopy and US-ANPB
Medical thoracoscopy was done in group I using a rigid thora-
coscope under mild sedation and local anesthesia. Biopsy spec-
imens were taken from abnormal sites of parietal pleura.
Biopsy specimens after being ﬁxed in formalin were sent to
the pathology department for histopathology analysis and
for bacteriologic investigation, including a search for
Mycobacterium tuberculosis.
Abrams needle biopsy was done in group II after determi-
nation of the site for entry selected and marked on the skin
as the most suitable and accessible part of the lesion with the
aid of an ultrasound done for each patient by the US appara-
tus present in the bronchoscopy room (Figs. 1–3).
Results
The total number of patients included in the study was 30, 24
males and 6 females. The characteristics of patients included in
the study are shown in table 1. The mean age was 56.5
± 14.2 years in group I and 58.0 ± 12.2 in group II. There
were no signiﬁcant differences in terms of sex (p = 0.641),
age (p = 0.223), or side of effusion. Pleural thickening in cases
of both groups is also shown in Table 1. 8 cases of group I were
diagnosed as pleural thickening as compared to 7 cases of
group II. There was no statistical signiﬁcant difference between
the 2 groups as regards pleural thickening.
Table 2 shows the distribution of diagnoses in cases of both
groups. In group I (medical thoracoscopy group), 13 cases
(86.5%) were diagnosed as malignant and 2 cases (13.5%) as
inﬂammatory lesions. Malignant mesothelioma was diagnosed
in 7 cases (46.2%) (conﬁrmed with positive immunohistochem-
ical examination by L-Calretinin (Figs. 4–6), metastatic pleural
disease in 6 cases (39.6%) of which 5 cases (33%) were of
unknown primary and 1 case (6.6%) was a known primary
carcinoma of the breast. The remaining 2 cases included tuber-the use of image guided pleural biopsy using abram’s needle and medical tho-
2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.003
Figure 1 The ultrasound apparatus.
Figure 2 Ultrasonographic examination of the pleura.
Figure 3 Ultrasound image of the pleura showing massive
amount of right sided pleural effusion and lung atelectasis.
Image guided pleural biopsy and medical thoracoscope 3culous deposits in 1 case (6.6%) and non-speciﬁc pleurisy in 1
case (6.6).
In group II (ultrasound-guided Abrams needle biopsy
group), 8 cases (52.8%) were diagnosed as malignant and 7
cases (47.2%) as inﬂammatory lesions. Malignant mesothe-
lioma was diagnosed in 4 cases (26.7%), metastatic pleural dis-
ease in 4 cases (26.7%) of which 2 cases (13.3%) were of
unknown primary and 2 cases (13.3%) were of known primary
carcinoma of the breast. The remaining 7 cases included tuber-
culous deposits in 1 case (6.6%) and non-speciﬁc pleurisy in 6
cases (39.6%).
Table 3 shows the sensitivity and speciﬁcity of diagnostic
thoracoscopy in group I was 100% & 100% respectively.
The sensitivity and speciﬁcity of ultrasound-guided Abrams
needle in group II was 100% & 100%, respectively. No differ-Table 2 Distribution of diagnoses of patients of both groups.
Diagnosis Gp 1 (n = 15
No. %
Malignant mesothelioma 7
Metastatic pleural disease of unknown primary 5
Metastatic pleural disease from breast cancer 1
Tuberculous deposits 1
Non-speciﬁc pleurisy 1
Please cite this article in press as: E.G. Hassanein et al., Comparative study between
racoscope in diagnosis of exudative pleural eﬀusion, Egypt. J. Chest Dis. Tuberc. (ence was identiﬁed between the sensitivities or speciﬁcities of
the two methods.
Fig. 7 shows the type and frequency of complications for
both methods. Complications encountered in group I included
failure of lung expansion in 12 (75%) patients [these patients
were managed by keeping intercostal tube in place for longer
time till full expansion occurred]. Local wound infection was
encountered in 6 patients (37.5%) and was managed by fre-
quent sterile dressings and local antibiotics, local antiseptic
solution and all resolved within 4–5 days. None of the cases
was complicated by empyema or pneumothorax. Subcuta-
neous emphysema was encountered in 4 patients (25%) and
resolved 1–2 days after the procedure. Complete lung expan-
sion occurred in 14 patients (93.7%) [after one day in (7)
patients, after 2 days in (5) patients, after 3 days in (2) patients]
and persistent effusion was encountered in 1 patient (6.3%).
Complications encountered in group II included local
wound infection in 4 patients (26.7%) and was managed by
frequent sterile dressings and local antibiotics, local antiseptic
solution and all resolved within 4–5 days. Pneumothorax
occurred in 3 cases (20%). Complete lung expansion occurred
in 15 patients (100%) [Just after the procedure]. Failure of lung
expansion and subcutaneous emphysema were not observed in
any case in group II. As for comparing chest tube blockage
incidence as a complication in the two studied groups, it was
found that it was signiﬁcantly higher in group I than group
2 (p = 0.000).
Discussion
The advantage of image-guided biopsies over blind pleural
biopsy in diagnosing pleural diseases has been shown to be) Gp 2 (n = 15)
No. %
P value
46.2 4 26.7 0.269
33 2 13.3 0.130
6.6 2 13.3 0.484
6.6 1 6.6 0.742
6.6 6 39.6 0.14
the use of image guided pleural biopsy using abram’s needle and medical tho-
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Figure 4 Thoracoscopic biopsy of parietal pleural nodule.
Figure 5 Calretinin immunostain in malignant mesothelioma.
Figure 6 Plain X-ray after thoracoscopy and pleurodesis.
Table 3 Comparison between sensitivity and speciﬁcity of
both groups.
Sensitivity Speciﬁcity
Gp I (Medical Thoracoscopy) 100% 100%
Gp II (US-ANPB) 100% 100%
4 E.G. Hassanein et al.clear especially with a reported number of methods that aim to
increase the diagnostic yield [14,21,22].
Image-guided biopsies performed under US or CT guidance
allows focal pleural thickening or nodules to be biopsied accu-
rately and safely. The choice between CT- and US-guided tech-
niques is dependent upon expertise, cost and equipment. US-
guided biopsy allows for real time visualization of the biopsy
needle with no radiation risk to the patient. During US-
guided biopsy patient movement due to heavy or rapid breath-
ing in dyspneic patients can be compensated for [24]. More-
over, US-guided pleural biopsy can be performed in
outpatient conditions [21,23–28].
US-guided biopsy is relatively accessible and requires min-
imal equipment. Obtaining biopsies can be carried out by a
suitably trained physician or radiologist without the need for
additional support staff. Usually, the procedure is well toler-
ated with local anesthesia while patient sedation is not
required. This allows for the establishment of a tissue diagnosis
in patients who are unable or too weak to undergo more inva-
sive tests. US-guided biopsies are often carried out as day-
cases and discharge is usually possible after a short period of
observation [29].Please cite this article in press as: E.G. Hassanein et al., Comparative study between
racoscope in diagnosis of exudative pleural eﬀusion, Egypt. J. Chest Dis. Tuberc. (The use of Abrams needle pleural biopsy still has a place in
the diagnosis of exudative pleural effusions and should not be
abandoned. This is because of its lower cost, simplicity, rela-
tively high safety, and diagnostic sensitivity for metastatic
pleural diseases and tuberculous pleurisy [30–33]. Reported
sensitivities range from 70% to 94%, and a number of studies
have reported 100% speciﬁcity [14,23–28]. Unlike cytology,
high yields are also found in the diagnosis of mesothelioma;
current literature quotes US to have a yield of 77% [21,27].
Since the blindness of the procedure of Abrams biopsy pre-
sents some limitation, medical thoracoscopy, where a sample is
taken based on visual observation overcomes this problem,
and the diagnostic sensitivity is notably high. Also the use of
biopsy under US guidance overcomes this problem [14]. When
the lesion in the pleural zone is located using US guidance,
diagnostic sensitivity is increased [24,32]. If biopsy taking by
Abrams needle could be performed in a bronchoscopy suite
under the guidance of US, it would bring about two advan-
tages: First, a simple and inexpensive method such as Abrams
pleural biopsy could be applied; second, US guidance already
ensured in the bronchoscopy room could be made use of in
increasing the diagnostic yield of the biopsy. The idea for the
present study arose in light of the above discussion.
In the present study, Abrams needle biopsy was performed
after the most probable lesion area was marked on the
patient’s skin, as determined by US of the chest before the
biopsy procedure. The US apparatus was already present in
the bronchoscopy unit, so there was no additional cost or extra
effort of transport to the standard application technique of
Abrams needle.
In the present study, cytology of pleural ﬂuid for malignant
cells was negative in all cases; therefore we proceeded to thora-
coscopy to identify the type of this malignancy which is neces-
sary to plan adequately the proper treatment.the use of image guided pleural biopsy using abram’s needle and medical tho-
2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.003
Figure 7 the type and frequency of complications for both methods.
Image guided pleural biopsy and medical thoracoscope 5Sophie et al. reported that thoracoscopy is indicated in case
of pleural ﬂuid being suggestive or positive for malignancy
[32]. Similarly, Boutin et al. reported that it was difﬁcult to
determine the type and origin of cancer by thoracentesis, so
thoracoscopic biopsy is highly needed even in positive pleural
ﬂuid for malignant cells [33]. Loddenkemper et al. and
Schwartz et al. recommended that thoracoscopic biopsy is
indicated if pleural ﬂuid is positive for malignant cells from
cancer breast in order to provide tissue suitable for hormone
receptor assay to guide hormonal therapy [34,35].
In the present study, deﬁnitive histopathological diagnosis
was achieved in all studied cases (100% in both groups). In
group I (medical thoracoscopy group), 13 cases (87.5%) were
diagnosed as malignant deposits and 2 cases (12.5%) as inﬂam-
matory lesions as compared to 8 cases (53.3%) diagnosed as
malignant deposits and 7 cases (46.7%) as inﬂammatory
lesions in group II (ultrasound-guided Abrams needle biopsy
group). There was no signiﬁcant difference between the sensi-
tivity of the two groups regarding diagnosis of malignant pleu-
ral diseases or tuberculous pleurisy.
In the present study, the sensitivity and speciﬁcity of diag-
nostic thoracoscopy in group I was 100% & 100% respec-
tively, signifying a high diagnostic yield of rigid
thoracoscope. The diagnostic sensitivity in previous thoraco-
scopic studies varied from 66 to 100% [36–42].
The sensitivity and speciﬁcity of ultrasound guided Abrams
needle in group II of our study was 100% & 100% respec-
tively, signifying a high diagnostic yield of ultrasound-guided
Abrams needle. The diagnostic sensitivity in previous ultra-
sound guided Abrams needle studies varied from 47% to
87% and speciﬁcity recorded 100% [43–45].
No difference was identiﬁed between the sensitivities of the
two methods in the present study.
Regarding the pleural thickness, there was no statistical sig-
niﬁcant difference between the 2 groups. Maskell and col-
leagues found that in patients with a pleural thickness 5 mm,
image-guided needle biopsy showed sensitivity of 75%.
When the two methods were compared in terms of compli-
cations, both were observed to be safe with mostly mild, con-
trolled and reversible complications. There was no signiﬁcant
difference between both groups as regards complications. As
for comparing chest tube blockage incidence as a complicationPlease cite this article in press as: E.G. Hassanein et al., Comparative study between
racoscope in diagnosis of exudative pleural eﬀusion, Egypt. J. Chest Dis. Tuberc. (in the two studied groups, it was found that it was signiﬁcantly
higher in group I than group II (p = 0.000).
Finally, it is concluded that if US guidance can be used for
biopsies performed with an Abrams needle, the yield of this
traditional method can be increased. US-ANPB has many
advantages added to its comparable diagnostic yield to medical
thoracoscopy and so the use of US-ANPB should be revived.
However, in occasions in which small single lesions are located
in sites that may be difﬁcult to reach with an Abrams needle,
such as posterior to the scapula or adjacent to the vertebral
column or the sternum, thoracoscopy is preferred. On the
other hand, for some cases an additional advantage of thora-
coscopy is that diagnostic and therapeutic aims, such as drai-
nage and pleurodesis, can be achieved in a single session.
The use of US-guided Abram‘s needle pleural biopsy is simple,
safe and well tolerated.
References
[1] N.A. Maskell, R.J. Butland Pleural Diseases Group, Standards
of Care Committee, British Thoracic Society, BTS guidelines for
the investigation of a unilateral pleural effusion in adults,
Thorax 58 (Suppl. 2) (2003) ii8–ii17.
[2] R.H. Poe, R.H. Israel, M.J. Utell, W.J. Hall, D.W. Greenblatt,
M.C. Kallay, Sensitivity, speciﬁcity, and predictive values of
closed pleural biopsy, Arch. Intern. Med. 144 (1984) 325–328.
[3] U.B. Prakash, H.M. Reiman, Comparison of needle biopsy with
cytologic analysis for the evaluation of pleural effusion: analysis
of 414 cases, Mayo Clin. Proc. 60 (1985) 158–164.
[4] K.V. Nance, R.W. Shermer, F.B. Askin, Diagnostic efﬁcacy of
pleural biopsy as compared with that of pleural ﬂuid
examination, Mod. Pathol. 4 (1991) 320–324.
[5] B.C. Escudero, C.M. Garcia, C.B. Cuesta, et al, Cytologic and
bacteriologic analysis of ﬂuid and pleural biopsy specimens with
Cope’s needle: study of 414 patients, Arch. Intern. Med. 150
(1990) 1190–1194.
[6] J.R. Tomlinson, S. Sahn, Invasive procedures in the diagnosis of
pleural disease, Semin. Respir. Med. 9 (1987) 30–36.
[7] P. Mestitz, M.J. Purves, A.C. Pollard, Pleural biopsy in the
diagnosis of pleural effusion: a report of 200 cases, Lancet 2
(1958) 1349–1353.
[8] B. Frist, A.V. Kahan, L.G. Koss, Comparison of the diagnostic
values of biopsies of the pleura and cytologic evaluation of
pleural ﬂuids, Am. J. Clin. Pathol. 72 (1979) 48–51.the use of image guided pleural biopsy using abram’s needle and medical tho-
2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.003
6 E.G. Hassanein et al.[9] J. Scerbo, H. Keltz, D.J. Stone, A prospective study of closed
pleural biopsies, JAMA 218 (1971) 377–380.
[10] A.A. Renshaw, B.R. Dean, K.H. Antman, D.J. Sugarbaker, E.
S. Cibas, The role of cytologic evaluation of pleural ﬂuid in the
diagnosis of malignant mesothelioma, Chest 111 (1997) 106–109.
[11] British Thoracic Society Standards of Care Committee,
Statement on malignant mesothelioma in the United
Kingdom, Thorax 56 (2001) 250–265.
[12] J. Peto, J.T. Hodgson, F.E. Matthews, J.R. Jones, Continuing
increase in mesothelioma mortality in Britain, Lancet 345 (1995)
535–539.
[13] N.A. Maskell, F.V. Gleeson, R.J.O. Davies, Standard pleural
biopsy versus CT-guided cutting-needle biopsy for diagnosis of
malignant disease in pleural effusions: a randomised controlled
trial, Lancet 361 (9366) (2003) 1326–1330.
[14] L.D. Abrams, New inventions: a pleural-biopsy punch, Lancet 1
(1958) 30–31.
[15] N.K.E. DeFrancis, Needle biopsy of the parietal pleura, N.
Engl. J. Med. 252 (1955) 948–949.
[16] W.R. Salyer, J.C. Eggleston, Y.S. Erozan, Efﬁcacy of pleural
needle biopsy and pleural ﬂuid cytopathology in the diagnosis of
malignant neoplasm involving the pleura, Chest 67 (1975) 536–
539.
[17] D.-M. Koh, S. Burke, N. Davies, S.P.G. Padley, Transthoracic
US of the chest: clinical uses and applications, Radiographics 22
(2002).
[18] D.B. Chang, P.C. Yang, K.T. Luh, S.H. Kuo, C.J. Yu,
Ultrasound-guided pleural biopsy with Tru-Cut needle, Chest
100 (1991) 1328–1333.
[19] M.M. Kamel, K. Kaffas, Diagnostic value of ultrasound guided
biopsy in patients with malignant pleural effusion, Egyp. J.
Chest Dis. Tuberculosis 61 (4) (2012), 377-38.
[20] A. Heilo, A.E. Stenwig, O.P. Solheim, Malignant pleural
mesothelioma: US-guided histologic core-needle biopsy,
Radiology 211 (1999) 657–659.
[21] N.M. Rahman, F.V. Gleeson, Image-guided pleural biopsy,
Curr. Opin. Pulm. Med. 14 (2008) 331–336.
[22] D.B. Chang, P.C. Yang, K.T. Luh, et al, Ultrasound-guided
pleural biopsy with Tru-Cut needle, Chest 100 (1991) 1328–
1333.
[23] R.F. Adams, W. Gray, R.J. Davies, et al, Percutaneous image-
guided cutting needle biopsy of the pleura in the diagnosis of
malignant mesothelioma, Chest 120 (2001) 1798–1802.
[24] R.E. Benamore, K. Scott, C.J. Richards, et al, Image-guided
pleural biopsy: diagnostic yield and complications, Clin. Radiol.
61 (2006) 700–705.
[25] E.M. Scott, T.J. Marshall, C.D. Flower, et al, Diffuse pleural
thickening: percutaneous CT-guided cutting needle biopsy,
Radiology 194 (1995) 867–870.
[26] M. Metintas, N. Ozdemir, S. Isiksoy, et al, CT-guided pleural
needle biopsy in the diagnosis of malignant mesothelioma, J.
Comput. Assist. Tomogr. 19 (1995) 370–374.
[27] P.R. Mueller, S. Saini, J.F. Simeone, et al, Image-guided pleural
biopsies: indications, technique, and results in 23 patients,
Radiology 169 (1988) 1–4.
[28] Giles Dixon, Duneesha de Fonseka, Nick Maskell, Pleural
controversies: image guided biopsy vs. thoracoscopy forPlease cite this article in press as: E.G. Hassanein et al., Comparative study between
racoscope in diagnosis of exudative pleural eﬀusion, Egypt. J. Chest Dis. Tuberc. (undiagnosed pleural effusions?, J Thorac. Dis. 7 (6) (2015)
1041–1051.
[29] B. Chakrabarti, I. Ryland, J. Sheard, C.J. Warburton, J.E.
Earis, The role of Abrams percutaneous pleural biopsy in the
investigation of exudative pleural effusions, Chest 129 (6) (2006)
1549–1555.
[30] R.J. Davies, F.V. GleesonPleural Diseases Group, Standards of
Care Committee, British Thoracic Society, Introduction to the
methods used in the generation of the British Thoracic Society
guidelines for the management of pleural diseases, Thorax 58
(Suppl. 2) (2003) ii1–ii7.
[31] R.F. Adams, F.V. Gleeson, Percutaneous image-guided cutting
needle biopsy of the pleura in the presence of a suspected
malignant effusion, Radiology 219 (2) (2001) 510–514.
[32] V.F. Sophie, J.C. Robin, The Portsmouth thoracoscopy
experience, an evaluation of service by retrospective case note
analysis, Respir. Med. 101 (2007) 1021–1025.
[33] C. Boutin, J.R. Viallat, P. Cargnino, Thoracoscopy in malignant
pleural effusions, Am. Rev. Respir. Dis. 124 (5) (1981) 588–592.
[34] R. Loddenkemper, I.I. Grosser, A. Gablcr, Prospective
evaluation of biopsy methods in the diagnosis of malignant
pleural effusions: in patient comparison between pleural ﬂuid
cytology, blind needle biopsy and thoracoscopy, Am. Rev.
Respir. Dis. 127 (1983) 114.
[35] C. Schwartz, H. Lu¨bbert, W. Rahn, N. Schnfeld, M. Serke, R.
Loddenkemper, Medical thoracoscopy: hormone receptor
content in pleural metastases due to breast cancer, Eur.
Respir. J. 24 (2004) 728–730.
[36] Z. Assi, J.L. Caruso, J. Herndon, Cytologically proved
malignant pleural effusions: distribution of transudates and
exudates, Chest 113 (1998) 1302–1304.
[37] A.C. Davidson, R.J. George, C.D. Sheldon, G. Sinha, B. Corrin,
D.M. Geddes, Thoracoscopy: assessment of physician service
and comparison of a ﬂexible bronchoscope used as a
thoracoscope with a rigid thoracoscope, Thorax 43 (1988)
327–332.
[38] R.P. George, G. Kevin, Diagnostic ﬂexible ﬁberoptic
pleuroscopy in suspected malignant pleural effusions, Chest
107 (1995) 424–429.
[39] M. Hansen, P. Faurschou, P. Clementsen, Medical
thoracoscopy, results and complications in 146 patients: a
retrospective study, Respir. Med. 92 (1998) 228–232.
[40] A.O. Carlos, L.L. Rafael, L.G. Ce´sar, Iodopovidone pleurodesis
for recurrent pleural effusions, Chest 122 (2002) 581–583.
[41] W.L. Law, W.M. Johnny, L. Samuel, C.K. Ng, C.K. Lo, W.K.
Ng, K.K. Ho, Y.W. Mok, Pleuroscopy : our initial experience in
Hong Kong, Hong Kong Med. J. 14 (2008) 178–184.
[42] L.R. Kaiser, J.E. Bavaria, Complications of thoracoscopy, Ann.
Thorac. Surg. 56 (1993) 796–798.
[43] R.F. Adams, F.V. Gleeson, Percutaneous image-guided cutting-
needle biopsy of the pleura in the presence of a suspected
malignant effusion, Radiology 219 (2001) 510–514.
[44] R.F. Adams, W. Gray, R.J. Davies, F.V. Gleeson, Percutaneous
image guided cutting needle biopsy of the pleura in the diagnosis
of malignant mesothelioma, Chest 120 (2001) 1798–1802.
[45] N.J. Screaton, C.D. Flower, Percutaneous needle biopsy of the
pleura, Radiol. Clin. North Am. 38 (2000), 293-30.the use of image guided pleural biopsy using abram’s needle and medical tho-
2016), http://dx.doi.org/10.1016/j.ejcdt.2016.09.003
